China sanctions introducing new intelligence and lowering the blood glucose medicine

China sanctions introducing new intelligence and lowering the blood glucose medicine
One kind not only can lower blood glucose can reduce the new " intelligence " taking place in hypoglycemia effectively but also Therapeutic medicine of diabetes - -The profit draws stupid peptide (promise and strength) ,Will enter China formally in June of this year, will offer new using the medicine choice to inland patient. National food medicines supervise the information that the administration bureau offers today claiming, have already sanctioned using this kind of " one kind of peptide analogs of glucagon of pancreas " (glp-1) Treat adult's 2 type diabetes.
Diabetes of Chinese Medical Association preside over the China clinical trial of these medicine learns the endocrine professor Yang WenYing of former General Board, Chinese-Japan Friendship Hospital how to point out, glp-1 is by a kind of synthetic polypeptide of intestinal cell, the difference that it and traditional oral administration lower candy medicine and insulin is, can follow the horizontal level of internal glucose " Press needing " Regulate insulin to secrete: Release insulin when internal blood glucose is too high; Blood glucose reaches normal standard time, make it keep steadily; Thus realize " Intelligence " Lower the intersection of candy and result, take place hypoglycemia risk minimize.
It also has human body's one's own endocrine of simulation at the same time, protects the function of Langerhans' islits ��'s cell function. More than 4000 clinical research which diabetics launches to more than 40 countries that have already been finished prove, it can improve quantity and quality that insulin of ��'s cell secretes, delays the development process of diabetes. Especially it only needs to use medicine once every day, and can give medicine any time, is not limited by the meal time, can be maximum to facilitate a patient.
According to knowing, by last May, this medicine has already been sanctioned being used for treating adult's 2 type diabetes by 27 countries such as Japan, Norway, Mexico, Iceland, Switzerland, Canada, Russia. The diabetic in China Mainland has already been up to 92 million people, and have illness coming on and still show a tendency to increase at present; China's rural crowd's diabetic morbidity is 8.2%, the urban crowd is 11.4; The young man and middle age men is ill to lead the growth rate to be already higher than the old crowd.
|